Early cancer diagnosis: reaching targets across whole populations amidst setbacks
Open Access
- 9 February 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 124 (7), 1181-1182
- https://doi.org/10.1038/s41416-021-01276-2
Abstract
Early diagnosis of cancer, followed by timely and appropriate therapy, are the cornerstones of the secondary prevention of cancer, thus the NHS has set a 2028 target to achieve 75% early stage (TNM I/II) at cancer diagnosis. In this context, Barclay et al. evaluated overall, sex, age and deprivation-group-specific progress towards this target based on 202,000 cancer patients diagnosis in 2015. Herein, we discuss their findings which form a valuable pre-COVID-19 pandemic status. We discuss the impact of the pandemic and the efforts being made in innovative early detection and diagnosis research.Keywords
This publication has 13 references indexed in Scilit:
- Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database AnalysisGut, 2021
- Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort StudyJournal of Clinical Oncology, 2021
- A roadmap for the early detection and diagnosis of cancerThe Lancet Oncology, 2020
- WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screeningGut, 2020
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling studyThe Lancet Oncology, 2020
- Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International EvidenceFrontiers in Oncology, 2019
- Variation in geographical treatment intensity affects survival of non-small cell lung cancer patients in EnglandCancer Epidemiology, 2018
- Cancer incidence and mortality projections in the UK until 2035British Journal of Cancer, 2016
- Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysisThe Lancet, 2016
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014